BD

BD is a global medical technology company that is advancing the world of health. With a founding year of 2004, BD has become one of the largest global medical technology companies worldwide. The company is dedicated to improving medical discovery, diagnostics, and the delivery of care. BD's headquarters is located in the United States and it has a workforce of over 70,000 employees who are committed to enhancing the safety and efficiency of clinicians' care delivery process. BD develops innovative technology, services, and solutions to advance clinical therapy for patients and the clinical process for health care providers. The company's focus on enabling laboratory scientists to accurately detect disease and advancing researchers' capabilities has contributed to its success in addressing global health challenges. BD collaborates with organizations worldwide to address these challenges and improve health care outcomes. The company's efforts aim to lower costs, increase efficiencies, improve safety, and expand access to health care on a global scale. Although there is no available information about the last investment and the last investors in BD, the company's strong presence in the medical technology industry and its commitment to advancing health care worldwide position it as a potential investment opportunity for venture capitalists. With a clear mission and widespread impact, BD stands out as a company with the potential to yield significant returns for investors in the Information Technology sector. For more detailed information on BD, visit bd.com.